Bayer Q3 Results - Q3 Top Pharma Company Earnings Reports

View Bayer's Q3 Earnings Report


  • Bayer HealthCare posted another strong performance in the third quarter, with earnings up by a double-digit percentage.
  • Sales of the subgroup rose by 3.5 percent (Fx & portfolio adj. 4.2 percent) to EUR 3,936 million (Q3 2008: EUR 3,802 million).
  • The Pharmaceuticals segment raised sales by 3.0 percent (Fx & portfolio adj. 3.8 percent) to EUR 2,548 million, performing especially well in Asia and Latin America

Check out Pfizer's current earnings estimates from CNN Money

Bayer's Website:

Bayer Q3 Results - Q3 Top Pharma Company Earnings Reports

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.